<DOC>
	<DOCNO>NCT02802059</DOCNO>
	<brief_summary>This study evaluate long term effect E. coli strain Nissle 1917 ( EcN-Suspension ) probiotic bacteria administration number , bacterial viral infection first 24 month infant 's life . Half study participant receive EcN-Suspension , half receive placebo .</brief_summary>
	<brief_title>E. Coli Nissle 1917 - Suspension Infection Prophylaxis</brief_title>
	<detailed_description>In course present trial participant observe first 24 month life , start right birth . All newborn meet inclusion criterion non-fulfiling exclusion criterion include trial . Each participant clinical trial randomly allocate one two trial arm , use method randomly permute block . The newborn primarily treat first three week life re-treated 6 12 month accord trial interventional plan . Data efficacy safety record control visit first month , 6 , 12 , 18 24 month .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>Signed informed consent form parent Age inclusion : max . 120 hour birth Functionally mature infant Gestational age 35th week development Mother 's intention breastfeed participant Readiness mother administer probiotic additionally trial medication Nonfulfilment least one inclusion criterion Lack propensity/compliance mother 5 min APGAR SCORE less 5 10 min APGAR SCORE less 8 pH umbilical cord blood le 7 Any perinatal infection require antibiotic treatment Birth weight less 2000 g TORCHinfection mother HIVinfection mother Any severe medical condition mother newborn opinion investigator may critical impact conduct study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Hours</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>